@article{ATM27939,
author = {Nicolás Monteverde-Fernández and Federico Cristiani and Jenniffer McArthur and Sebastián González-Dambrauskas},
title = {Steroids in pediatric acute respiratory distress syndrome},
journal = {Annals of Translational Medicine},
volume = {7},
number = {19},
year = {2019},
keywords = {},
abstract = {Acute respiratory distress syndrome (ARDS) is a complex entity with high potential for harm and healthcare resource utilization. Despite multiple clinical advances in its ventilatory management, ARDS continues to be one of the most challenging disease processes for intensivists. It continues to lack a direct, proven and desperately needed effective therapeutic intervention. Given their biologic rationale, corticosteroids have been widely used by clinicians and considered useful by many in the management of ARDS since its first description. Adult data is abundant, yet contradictory. Controversy remains regarding the routine use of corticosteroids in ARDS. Therefore, widespread evidence-based recommendations for this heterogeneous disease process have not been made. In this article, our aim was to provide a summary of available evidence for the role of steroids in the treatment of ARDS, while giving special focus on pediatric ARDS (PARDS).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/27939}
}